INTERNATIONAL PATENT: EGLE THERAPEUTICS, INSTITUT CURIE FILES APPLICATION FOR "IL18R AGONIST ANTIBODIES AND USES THEREOF"

GENEVA, Dec. 1 -- EGLE THERAPEUTICS (5 rue Gardenat Lapostol92150 SURESNES), INSTITUT CURIE (26 rue d'Ulm75005 PARIS) filed a patent application (PCT/EP2025/064388) for "IL18R AGONIST ANTIBODIES AND USES THEREOF" on May 23, 2025. With publication no. WO/2025/242910, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEMOINE, Sebastien (30, rue Jean Giraudoux95130 Le Plessis Bouchard), NEVO, Fabien (49 Avenue de la Republique77340 PONTAULT-COMBAULT), KOTSIAS, Fiorella (Palpa 3076 (1426)Ciudad Autonoma de Buenos Aires), TKACH,...